Racial Differences in the Pharmacokinetics of Methylprednisolone in Black and White Renal Transplant Recipients

Study Objective. To examine the comparative pharmacokinetics of long‐term methylprednisolone therapy in black and white renal transplant recipients.

• Publication year

  1993

• Venue

  Pharmacotherapy

• Publication date

  1993-09-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/j.1875-9114.1993.tb04311.xPMID 8247916
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetics and pharmacodynamics of methylprednisolone in obesity

  1991cited by this paper
• Theophylline Pharmacokinetics in Black Zimbabwean Males

  1990cited by this paper
• Racial differences in drug response: Isoproterenol effects on heart rate following intravenous metoprolol

  1989cited by this paper
• The immune-hypothalamic-pituitary-adrenal axis.

  1989cited by this paper
• Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects

  1989cited by this paper
• Methylprednisolone disposition in renal transplant recipients receiving triple-drug immunosuppression.

  1989cited by this paper
• Influence of race of cadaveric kidney donor and recipient on graft survival: a multifactorial analysis.

  1987cited by this paper
• Pharmaceutical Statistics: Practical and Clinical Applications

  1985cited by this paper
• Immunosuppressive agents in renal transplantation.

  1984cited by this paper
• Analysis of cortisol, methylprednisolone, and methylprednisolone hemisuccinate. Absence of effects of troleandomycin on ester hydrolysis.

  1984cited by this paper
• LAGRAN program for area and moments in pharmacokinetic analysis.

  1983cited by this paper
• Racial differences in the incidence of steroid diabetes in renal transplant patients.

  1982cited by this paper
• Altered theophylline clearance during an influenza B outbreak.

  1982cited by this paper
• Endogenous hydrocortisone, a possible factor contributing to the genesis of cushingoid habitus in patients on prednisone.

  1981cited by this paper
• Inhibition of hepatic drug metabolism in VX2 carcinoma-bearing rabbits.

  1980cited by this paper
• Pathophysiology of Hypertension in Blacks and Whites: A Review of the Basis of Racial Blood Pressure Differences

  1979cited by this paper
• Racial differences in drug metabolizing ability: A study with antipyrine in the Sudan

  1978cited by this paper
• Factors affecting antipyrine metabolism in West African villagers

  1976cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper
• [Glucocorticoid therapy].

  1969cited by this paper
• [Side effects of glucocorticoid therapy].

  1968cited by this paper

• Risk factors for administration of additional reversal following neuromuscular blockade with rocuronium in children: A retrospective case–control study

  2022cites this paper
• Glucocorticoids pharmacology and their application in the treatment of childhood-onset systemic lupus erythematosus.

  2019cites this paper
• Gender-based personalized pharmacotherapy: a systematic review

  2017cites this paper
• Ethnic Differences in Osteoporosis After Cardiac Transplantation.

  2017cites this paper
• Steroids in kidney transplant patients

  2011cites this paper
• Herpes zoster incidence in a multicenter cohort of solid organ transplant recipients

  2011cites this paper
• Responses to tiotropium in African-American and Caucasian patients with chronic obstructive pulmonary disease.

  2008cites this paper
• Review in pharmacokinetic models on corticosteroids.

  2006cites this paper
• Pharmacokinetics and Pharmacodynamic Response of Methylprednisolone in Premenopausal Renal Transplant Recipients

  2004influential citation
• A Review and Assessment of Potential Sources of Ethnic Differences in Drug Responsiveness

  2003cites this paper
• Prednisolone Pharmacokinetics and Pharmacodynamics in Relation to Sex and Race

  2001cites this paper
• Use of Corticosteroids in Kidney Transplantion

  2001cites this paper
• Pharmacokinetic characteristics of methylprednisolone in Korean renal transplant recipients.

  1999cites this paper
• Human variability and noncancer risk assessment--an analysis of the default uncertainty factor.

  1998cites this paper
• An increased incidence of rejection episodes. One of the causes of worse kidney transplantation survival in black recipients.

  1997cites this paper
• Post-Transplant Diabetes Mellitus

  1997cites this paper
• Methylprednisolone pharmacodynamics assessed by antilymphocyte action in kidney transplantation: clinical relevance and utility.

  1996cites this paper
• Pharmacokinetics of Prednisolone During Administration of Sirolimus in Patients with Renal Transplants

  1996cites this paper
• Donor race does not affect cadaver kidney transplant survival--a single center experience.

  1995cites this paper
• Post‐transplant diabetes mellitus and methylprednisolone pharmacokinetics in African‐American and Caucasian renal transplant recipients

  1995cites this paper
• Diabetes pós-transplante renal: ocorrência, aspectos clínicos e possíveis fatores de risco

  1995cites this paper
• Pharmacokinetics of methylprednisolone during acute renal allograft rejection

  1995cites this paper
• Methylprednisolone pharmacokinetics, cortisol response, and adverse effects in black and white renal transplant recipients.

  1995cites this paper
• Pharmacokinetics of Methylprednisolone in Elderly and Young Healthy Males

  1994cites this paper